(Q46845039)

25 December 2017

title

Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis (English)

1 reference

25 December 2017

0 references

1 reference

Manco M

1

1 reference

25 December 2017

Marcellini M

2

1 reference

25 December 2017

Devito R

3

1 reference

25 December 2017

Comparcola D

4

1 reference

25 December 2017

Sartorelli MR

5

1 reference

25 December 2017

Nobili V

6

1 reference

25 December 2017

language of work or name

English

0 references

publication date

18 December 2007

1 reference

25 December 2017

International Journal of Obesity

published in

1 reference

25 December 2017

volume

32

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

381-387

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0803711

exact match

0 references

cites work

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Establishing a standard definition for child overweight and obesity worldwide: international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Histopathology of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Indexes of insulin resistance and secretion in obese children and adolescents: a validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

7 January 2021

Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

7 January 2021

Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

7 January 2021

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

7 January 2021

Glucose tolerance and insulin release, a mathematical approach I. Assay of the beta-cell response after oral glucose loading

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

7 January 2021

Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

7 January 2021

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803711

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0803711

1 reference

25 December 2017

PubMed ID

18087267

1 reference

25 December 2017